Following her own diagnosis with a locally advanced breast cancer in 1998, she has since devoted her energy to helping other survivors.

FORBES: Connect

Separately, Pfizer said that the Food and Drug Administration has approved Xalkori capsules, which the company calls the first-ever drug targeting anaplastic lymphoma kinase, or ALK, for the treatment of locally advanced or metastatic non-small cell lung cancer that is ALK-positive.

FORBES: Bristol-Myers, Pfizer Announce Positive Results; An FDA Approval for Pfizer